AI News NQ Analysis

Self-paid Anti-Influenza Drug Shufuxiao Once Short, Failure to Report in Advance Fined NT$60,000

NQ Score 0/100
N1 Content Completeness 0

AI Summary (NQ-processed)

Taiwan's Food and Drug Administration (FDA) fined Shionogi Pharmaceutical NT$60,000 for failing to report in advance the shortage of the self-paid anti-influenza drug "Shufuxiao Film-Coated Tablets 20mg," a necessary medicine. The drug's supply has normalized since February 5, 115 (2026).

AI Analysis